Global Coalition Urges Regulatory Convergence On COVID-19 Vaccines
More Funding Still Needed For COVAX Initiative
Executive Summary
Mutual recognition of approvals and simplified rules on labeling could help to make COVID-19 vaccines more accessible to populations around the world.
You may also be interested in...
Coronavirus Notebook: Moderna Renounces COVID-19 Patents, China Joins COVAX
The CEPI coalition plans a global network to assess and compare the immunological responses generated by COVID-19 vaccine candidates, and a trial gets under way to test whether the BCG vaccine can afford some immunity against coronavirus.
Coronavirus Notebook: COVAX Wellcomes Latecomers, Sanofi/GSK Sign Canadian Supply Deal
The Australian government is investing in two candidate vaccines being developed in Melbourne, French firm Avaxia is looking at the virucidal potential of an antibacterial compound, and Canada has ordered millions of specialist vials and syringes from an advanced materials science firm based in Alabama.
EU Preparing Guidance On Synthetic Oligonucleotides & Peptides
Two new quality guidelines are needed to address the increase in applications for clinical trials and marketing authorizations of oligonucleotide- and peptide-based medicines, says the EU regulator.